Events
Extraordinary General Meeting
19 June 2020 3pm CET Møllendalsbakken 9, 5009 Bergen Due to the restrictions caused by…
Read More Jun 19, 2020 Møllendalsbakken 9, 5009 Bergen
BERGENBIO ASA: Invitation to first quarter 2020 results webcast presentation
Bergen, Norway, 13 May 2020 – BerGenBio ASA (OSE:BGBIO), will announce its results for the first…
Read More May 19, 2020 Webcast
ACCORD – BerGenBio’s bemcentinib selected for fast-tracked UK Government study
BerGenBio will be hosting a live webcast and Q&A session at 10:00 CEST today to…
Read More Apr 29, 2020 Online
BERGENBIO TO PRESENT AT THE UPCOMING 2020 SOLEBURY TROUT VIRTUAL INVESTOR CONFERENCE
Bergen, Norway, March 30, 2020 – BerGenBio, a clinical-stage biopharmaceutical company developing novel, selective AXL kinase inhibitors…
Read More Mar 31, 2020
Fourth quarter and full year 2019 results presentation and webcast
A presentation by BerGenBio’s senior management will take place 10am CET at: Hotel Continenal, Stortingsgaten…
Read More Feb 11, 2020 Hotel Continenal, Stortingsgaten 24/26, Oslo
BerGenBio to present clinical data from Phase II combination trial of bemcentinib and LDAC trial in elderly AML patients at ASH 2019
Poster presentation at ASH 2019 Date: Monday 9th December 2019 Session Name: 616. Acute Myeloid Leukemia: Novel…
Read More Dec 9, 2019 Orlando, Florida
Jonas Lies vei 91, 5009 Bergen, Norway
+ 47 559 61 159